U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06814314) titled 'AP Metabolism Transcriptomics' on Feb. 03.
Brief Summary: It is known from the literature that treatment with antipsychotic drugs (AP) induces, even before changes in blood chemistry parameters, changes in gene transcription that are evident at the level of peripheral blood mononuclear cells.
In this pilot study we intend to evaluate the transcriptomic profile of children and adolescents who are undergoing treatment with antipsychotics and show metabolic disorders, in order to compare it to the profile of similar patients who do not use antipsychotics, but show metabolic disorders, or who use antipsychotics, but do not show metaboli...